资讯

TMCnet33 分钟
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in ...
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) ...